Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-28,567
Closed -$3.74M 318
2023
Q3
$3.74M Buy
28,567
+24,444
+593% +$3.71M 0.34% 68
2023
Q2
$656K Sell
4,123
-13,836
-77% -$2.23M 0.06% 139
2023
Q1
$2.84M Sell
17,959
-27,602
-61% -$4.14M 0.27% 76
2022
Q4
$6.39M Buy
45,561
+23,292
+105% +$3.31M 0.64% 38
2022
Q3
$2.86M Buy
+22,269
New +$3.21M 0.3% 69
2022
Q1
Sell
-2,300
Closed -$401K 238
2021
Q4
$401K Buy
2,300
+1,085
+89% +$181K 0.04% 143
2021
Q3
$201K Sell
1,215
-846
-41% -$146K 0.02% 201
2021
Q2
$371K Buy
+2,061
New +$376K 0.04% 136

Other funds holding CLX

Trek Financial's CLX Position: Q4 2023 in Review

Trek Financial sold out of Clorox (CLX) in Q4 2023, closing a stake of 28,567 shares — an estimated $3.74M sold.

Trek Financial first reported a position in CLX in Q2 2021 and held it in 8 quarters. The position peaked at $6.39M in Q4 2022. 1,107 funds tracked by Wall St. Rank hold CLX as of Q4 2023.

  • Trek Financial reported no remaining Clorox position as of Q4 2023 after selling out during the quarter.
  • Trek Financial sold 28,567 Clorox shares in Q4 2023, an estimated $3.74M.
  • Trek Financial first reported a position in Clorox in Q2 2021 and held it in 8 quarters.
  • Trek Financial's Clorox position peaked at $6.39M in Q4 2022.
  • 1,107 funds tracked by Wall St. Rank held Clorox as of Q4 2023.

Based on Trek Financial's 13F filing for Q4 2023, filed 8 Feb 2024.